emjreviews.com
Surgery Helps Heal Metastatic Cutaneous Crohn's Disease - EMJ
This study suggests surgery can help heal severe, noncontiguous (metastatic) skin manifestations of Crohn’s disease when medical therapy alone isn’t enough. It highlights that realistic healing may take many months and often needs combined surgical and medical care.
Adults with Crohn’s disease who have refractory skin lesions or complex perineal disease, colorectal and plastic surgeons, gastroenterologists managing complex IBD, and wound-care teams.
What To Know
This report summarizes a retrospective case series of 11 adult patients with metastatic cutaneous Crohn’s disease treated at a tertiary UK centre between 2019–2024.
The authors describe multidisciplinary care combining medical and surgical approaches, with common surgical strategies including proctocolectomy and tailored perineal reconstruction; adjuncts such as topical tacrolimus, hyperbaric oxygen, and re-excision were also used.
At final follow-up (median 36 months) 81.8% had complete wound healing, emphasizing prolonged follow-up and careful patient selection. Surgery was generally considered for severe, refractory skin lesions that did not respond to optimized medical therapy.
The article highlights the role of coordinated colorectal and plastic surgical input, preoperative optimisation, and specialist wound-clinic follow-up to support healing and manage recurrence risk.
If reading the original paper could be useful, the article cites Selvakumar D et al., Surgical management of metastatic cutaneous Crohn’s disease: a case series (Tech Coloproctol, 2026) for full methods and detailed outcomes.
This is a small retrospective case series from a single tertiary centre and describes complex, selected cases; it does not establish comparative effectiveness or change standard first-line medical management. Outcomes depended on multidisciplinary care and long follow-up; details and generalisability are best evaluated by reading the full published paper.
